CAS: 86847-64-5; N-(3-Formylpyridin-2-yl)Pivalamide

该化合物是有机化合物,具有独特的结构特征,含有一种以气态组替代的环,有助于其在有机合成中的活性及潜在应用.氨基功能组的存在表明,它可以参与氢结合,影响其溶解性和沸点.碳链上的两个甲基组提供了僵化障碍,可能影响化合物的再活动及与其他分子的相互作用.该化合物可能展示生物活动,使其对药用化学感兴趣.其具体特性,如熔点,沸点和溶性,将取决于分子相互作用和研究该物质的环境.

结构式图片

相似化合物

127446-34-8 125867-25-6 902837-38-1

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号86847-59-8 2-特戊酰胺基吡啶 | CAS号68-12-2 N,N-二甲基甲酰胺 | CAS号4394-85-8 N-甲酰吗啉 | CAS号2591-86-8 1-甲酰哌啶 | CAS号109-72-8 正丁基锂 | CAS号3282-30-2 特戊酰氯 | CAS号504-29-0 2-氨基吡啶 | CAS号5174-90-3 2-氧-1,2-二氢-[1,8... | CAS号23612-57-9 2-氨基-3-羟甲基吡啶

合成工艺路线路线简述

  • 75-98-9 = 86847-64-5
    反应条件:1.1 Reagents: Oxalyl Chloride Catalysts: Dimethylformamide Solvents: Dichloromethane; 0 °C2.1 Reagents: Triethylamine Solvents: Tetrahydrofuran; 0 °C; 1 H,0 °C -> Rt3.1 Reagents: Butyllithium Solvents: Tetrahydrofuran; -20 °C -> 0 °C; 2 H,0 °C3.2 0 °C; 2 H,0 °C -> Rt
    标题:Regioselective Ketone α-Alkylation With Simple Olefins Via Dual Activation
    作者:Mo,Fanyang; Et Al
    参考文献:Science (Washington 日期:2014 卷标:345(6192) 页码:68-72]

    86847-59-8 = 86847-64-5
    反应条件:1.1 Reagents: Butyllithium Solvents: Tetrahydrofuran; -20 °C -> 0 °C; 2 H,0 °C1.2 0 °C; 2 H,0 °C -> Rt
    标题:Regioselective Ketone α-Alkylation With Simple Olefins Via Dual Activation
    作者:Mo,Fanyang; Et Al
    参考文献:Science (Washington 日期:2014 卷标:345(6192) 页码:68-72]

    = 86847-64-5
    反应条件:1.1 Reagents: Triethylamine Solvents: Tetrahydrofuran; 0 °C; 1 H,0 °C -> Rt2.1 Reagents: Butyllithium Solvents: Tetrahydrofuran; -20 °C -> 0 °C; 2 H,0 °C2.2 0 °C; 2 H,0 °C -> Rt
    标题:Regioselective Ketone α-Alkylation With Simple Olefins Via Dual Activation
    作者:Mo,Fanyang; Et Al
    参考文献:Science (Washington 日期:2014 卷标:345(6192) 页码:68-72
📜N-甲酰吗啉置于叔丁基锂体系中,用 乙醚,正戊烷,四氢呋喃 作为反应溶剂,化学反应 1.5H,以85%的收率获得产物2-(特戊酰氨基)吡啶-3-醛
参考文献:Ep1782811
标题:Ep1782811

海关参考信息

专利信息


专利号:WO-2008022467-A1
优先权日:2006-08-25
标 题 :2-substituted azain doles and 2 substituted thienopyrroles, their precursors and novel processes for the preparation thereof
发明人:LAUTENS MARK; YUEN JOSEPHINE; FANG YUANQING
权利人:LAUTENS MARK; YUEN JOSEPHINE; FANG YUANQING
摘要:The present invention relates generally to processes for the chemical synthesis of azaindole and thienopyrrole compounds, in particular azaindole and thienopyrrole compounds that are substituted at the 2-position of the azaindole or thienopyrrole ring, and optionally at additional locations of the azaindole or thienopyrrole ring such as the 1- and/or 3-position, compounds prepared by such processes, and synthetic precursors of such processes. More particularly, the present invention relates to the preparation of 2- substituted azaindoles from an ortho-gem-dihalovinylaminopyridine or from an ortho- gem-dihalovinylaminopyridine N-oxide compound and an organoboron reagent using a palladium metal pre-catalyst, base and a ligand. The present invention also relates to the preparation of 2-substituted thienopyrroles from an ortho-gem-dihalovinylthiophene compound and an organoboron reagent using a palladium metal pre-catalyst, base and a ligand. The present invention also relates to processes for the production of ortho-gem- dihalovinylaminopyridines which are useful as starting materials in the production of 2- substituted azaindoles, and novel compounds prepared by the processes. The present invention also relates to processes for the production of ortho-gem-dihalovinylthiophenes which are useful as starting materials in the production of 2-substituted thienopyrroles, and novel compounds prepared by the processes. Formulae (V) and (VII).

专利号:US-6410526-B1
优先权日:1999-06-02
标题 :αv integrin receptor antagonists
发明人:DUGGAN MARK E; HARTMAN GEORGE D; MEISSNER ROBERT S; PERKINS JAMES J
权利人:MERCK & CO INC
摘要:The present invention relates to novel nonanoic acid derivatives, their synthesis, and their use as alphav integrin receptor antagonists. More particularly, the compounds of the present invention are antagonists of the integrin receptors alphavbeta3 and alphavbeta5 and are useful for inhibiting bone resorption, treating and preventing osteoporosis, and inhibiting vascular restenosis, diabetic retinopathy, macular degeneration, angiogenesis, atherosclerosis, inflammation, inflammatory arthritis, viral disease, cancer, and metastatic tumor growth.

专利号:US-7056909-B2
优先权日:2000-07-26
标题 :Alpha v integrin receptor antagonists
发明人:WANG JIABING
权利人:MERCK & CO INC
摘要:The present invention relates to novel chain-fluorinated alkanoic acid derivatives thereof, their synthesis, and their use as αv integrin receptor antagonists. More particularly, the compounds of the present invention are antagonists of the integrin receptors αvβ3 and/or αvβ5 and are useful for inhibiting bone resorption, treating and preventing osteoporosis, and inhibiting vascular restenosis, diabetic retinopathy, macular degeneration, angiogenesis, atherosclerosis, inflammation, inflammatory arthritis, viral disease, cancer, and metastatic tumor growth.

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知